SE425392B - Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter - Google Patents

Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter

Info

Publication number
SE425392B
SE425392B SE7508789A SE7508789A SE425392B SE 425392 B SE425392 B SE 425392B SE 7508789 A SE7508789 A SE 7508789A SE 7508789 A SE7508789 A SE 7508789A SE 425392 B SE425392 B SE 425392B
Authority
SE
Sweden
Prior art keywords
benzomorphanes
tetrahydrofurfuryl
disubstituted
beta
procedure
Prior art date
Application number
SE7508789A
Other languages
English (en)
Swedish (sv)
Other versions
SE7508789L (sv
Inventor
H Merz
A Langbein
G Walther
K Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE7508789L publication Critical patent/SE7508789L/
Publication of SE425392B publication Critical patent/SE425392B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7508789A 1974-08-05 1975-08-04 Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter SE425392B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2437610A DE2437610A1 (de) 1974-08-05 1974-08-05 Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
SE7508789L SE7508789L (sv) 1976-02-10
SE425392B true SE425392B (sv) 1982-09-27

Family

ID=5922448

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7508789A SE425392B (sv) 1974-08-05 1975-08-04 Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter

Country Status (27)

Country Link
US (1) US3982005A (fi)
JP (1) JPS60358B2 (fi)
AT (1) AT348140B (fi)
BE (1) BE832099R (fi)
BG (3) BG25088A3 (fi)
CA (1) CA1049008A (fi)
CH (7) CH613963A5 (fi)
CS (1) CS189717B2 (fi)
DD (1) DD122685A5 (fi)
DE (1) DE2437610A1 (fi)
DK (1) DK138992C (fi)
ES (6) ES452767A1 (fi)
FI (1) FI63229C (fi)
FR (1) FR2320096A2 (fi)
GB (1) GB1513950A (fi)
HU (1) HU177952B (fi)
IE (1) IE42216B1 (fi)
IL (1) IL47860A (fi)
LU (1) LU73138A1 (fi)
NL (1) NL7509249A (fi)
NO (1) NO143460C (fi)
PH (1) PH13687A (fi)
PL (3) PL99819B1 (fi)
RO (3) RO67390A (fi)
SE (1) SE425392B (fi)
SU (3) SU591147A3 (fi)
ZA (1) ZA754997B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS5636521A (en) * 1979-08-31 1981-04-09 Shin Etsu Chem Co Ltd Production of alkenyloxy group-containing organopolysiloxane
CL2008002199A1 (es) 2007-07-26 2009-10-23 Vitae Pharmaceuticals Inc Compuestos derivados de 1,3-oxazin-2-ona; composicion farmaceutica que comprende a dichos compuestos; y uso para tratar una enfermedad asociada con la actividad de la 11beta-hidroxiesteroide deshidrogenasa tipo 1 (11beta-hsd1) tales como dislipidemia, hiperlipidemia, hipertension, obesidad y enfermedad cardiovascular, entre otras.
CL2008003407A1 (es) 2007-11-16 2010-01-11 Boehringer Ingelheim Int Compuestos derivados de aril- y heteroarilcarbonilo de heterobiciclo sustituido; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de trastornos metabolicos, mediado por la inhibicion de la enzima hsd-1.
US8440658B2 (en) 2007-12-11 2013-05-14 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
US8592409B2 (en) 2008-01-24 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
US8598160B2 (en) 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
US8138178B2 (en) 2008-05-01 2012-03-20 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5538365B2 (ja) 2008-05-01 2014-07-02 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
TW201004945A (en) 2008-05-01 2010-02-01 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8765780B2 (en) 2008-05-13 2014-07-01 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
CN102119160B (zh) 2008-07-25 2014-11-05 贝林格尔·英格海姆国际有限公司 11β-羟基类固醇脱氢酶1的环状抑制剂
WO2010010157A2 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
UY33001A (es) 2009-11-06 2011-05-31 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina
JP5860042B2 (ja) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
US8735585B2 (en) 2011-08-17 2014-05-27 Boehringer Ingelheim International Gmbh Indenopyridine derivatives
KR20230112134A (ko) 2020-11-26 2023-07-26 신에쓰 가가꾸 고교 가부시끼가이샤 실온경화성 오르가노폴리실록산 조성물 및 물품 그리고 가수분해성 오르가노실란 화합물 및 그 제조 방법
EP4397695A1 (en) 2021-09-03 2024-07-10 Shin-Etsu Chemical Co., Ltd. Organopolysiloxane compound, room temperature-curable organopolysiloxane composition, and article

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (fi) * 1958-09-22
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
DE2105743C3 (de) * 1971-02-08 1979-11-29 Boehringer Sohn Ingelheim 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
CS166804B2 (fi) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
DE2200596A1 (de) * 1972-01-07 1973-07-12 Boehringer Sohn Ingelheim N-(furyl-methyl)-2'-hydroxy-5-phenyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2229695A1 (de) * 1972-06-19 1974-01-31 Boehringer Sohn Ingelheim 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
SE7508789L (sv) 1976-02-10
BG25089A3 (en) 1978-07-12
ES452767A1 (es) 1977-10-01
DD122685A5 (fi) 1976-10-20
FR2320096A2 (fr) 1977-03-04
FI63229C (fi) 1983-05-10
IE42216B1 (en) 1980-07-02
NO143460C (no) 1981-02-18
US3982005A (en) 1976-09-21
CH616420A5 (fi) 1980-03-31
RO72735A (ro) 1982-09-09
JPS60358B2 (ja) 1985-01-07
SU587858A3 (ru) 1978-01-05
CH615677A5 (fi) 1980-02-15
ES452768A1 (es) 1977-10-01
ZA754997B (en) 1977-04-27
IL47860A0 (en) 1975-11-25
JPS5139673A (en) 1976-04-02
CA1049008A (en) 1979-02-20
DK138992C (da) 1979-04-30
ES452764A1 (es) 1977-10-16
PH13687A (en) 1980-09-01
RO67390A (ro) 1981-06-30
CH615680A5 (fi) 1980-02-15
SU587859A3 (ru) 1978-01-05
CH615678A5 (fi) 1980-02-15
RO72736A (ro) 1982-09-09
AT348140B (de) 1979-01-25
NO143460B (no) 1980-11-10
NO752731L (fi) 1976-02-06
ATA523775A (de) 1978-06-15
NL7509249A (nl) 1976-02-09
CH616421A5 (fi) 1980-03-31
ES452765A1 (es) 1977-10-16
DE2437610A1 (de) 1976-02-26
CH613963A5 (fi) 1979-10-31
BE832099R (fr) 1976-02-04
IL47860A (en) 1979-01-31
FI63229B (fi) 1983-01-31
PL99838B1 (pl) 1978-08-31
ES452766A1 (es) 1977-10-01
GB1513950A (en) 1978-06-14
CS189717B2 (en) 1979-04-30
FR2320096B2 (fi) 1978-09-01
DK352875A (da) 1976-02-06
AU8364675A (en) 1977-02-10
SU591147A3 (ru) 1978-01-30
BG25090A3 (en) 1978-07-12
BG25088A3 (en) 1978-07-12
IE42216L (en) 1976-02-05
HU177952B (en) 1982-02-28
FI752211A (fi) 1976-02-06
LU73138A1 (fi) 1977-04-13
CH615679A5 (fi) 1980-02-15
DK138992B (da) 1978-11-27
ES452763A1 (es) 1977-10-01
PL99819B1 (pl) 1978-08-31
PL99816B1 (pl) 1978-08-31

Similar Documents

Publication Publication Date Title
SE425392B (sv) Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter
DK140430B (da) Analogifremgangsmåde til fremstilling af 3-aryloxy-3-phenylpropylaminer eller syreadditionssalte heraf.
DK137188C (da) Analogifremgangsmaade til fremstilling af 2-tetrahydrofurfuryl-6,7-benzomorphaner eller syreadditionssalte heraf
SE426828B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner eller 6beta-acylamino-6alfa-alkoxipenicilliner
NO140427C (no) Fremgangsmaate til fremstilling av antibiotikum 1-n-(l-(-)-alfa-hydroksy-gamma-aminobutyryl)-xk-62-2 eller syreaddisjonssalter derav
DK441875A (da) Fremgangsmade til fremstilling af 2-phenyliminoimidazolidiner eller syreadditionssalte deraf
NO153299C (no) Fremgangsmaate for fremstilling av 6-d-alfa-amino-alfa-(p-hydroksy-fenyl)-acetamido-penicillansyre eller salter derav.
SE418085B (sv) Forfarande for framstellning av nya sulfamoylbensoesyraamider
DK131778C (da) Fremgangsmade til fremstilling af substituerede 3-hydroksymetylisokinolinderivater eller syreadditionssalte heraf
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
DK137606C (da) Analogifremgangsmaade til fremstilling af substituerede 2-phenylamino-imidazoliner-(2) eller syreadditionssalte deraf
DK137953B (da) Analogifremgangsmåde til fremstilling af amidoximderivater eller syreadditionssalte deraf.
DK139574B (da) Analogifremgangsmåde til fremstilling af terpeno-phenoxy-alkylaminer eller syreadditionssalte deraf.
DK131857C (da) Analogifremgangsmade til fremstilling af 4-hydroxymethyl-1-phthalazonderivater eller syreadditionssalte deraf
NO142627C (no) Fremgangsmaate for fremstilling av poly-alfa-hydroksyakrylsyrer eller av kopolymerer av poly-alfa-hydroksyakrylsyre
DK128779B (da) Analogifremgangsmåde til fremstilling af 2-arylamino-imidazolin-(2)'er eller syreadditionssalte deraf.
SE431216B (sv) Forfarande for framstellning av 1n-(alfa-hydroxi-omega-amino-alkanoyl)-6 721n-metyl-3 721, 4 721-dideoxikanamycin b eller farmaceutiskt godtagbara syraadditionssalter derav
DK134436C (da) Analogifremgangsmade til fremstilling af s(iv)-benzo-1,2,4-thiadiaziner eller syreadditionssalte deraf
DK138266B (da) Analogifremgangsmåde til fremstilling af basiske derivater af 1-aryl-2-oxo-2,4,5,6,7,7a-hexahydroindoler eller syreadditionssalte deraf.
DK132324C (da) Analogifremgangsmade til fremstilling af dibenzo(d,f)(1,3)dioxepiner eller alkalimetalsalte eller syreadditionssalte deraf
SE427181B (sv) Forfarande for framstellning av nya n-substituerade 6,7-bensomorfaner
DK137796B (da) Fremgangsmåde til fremstilling af 1-aryloxy-3-aminopropanolderivater eller syreadditionssalte deraf.
DK134752C (da) Analogifremgangsmade til fremstilling af(+)-3r-n-monomethyl-amino-4c-phenyl-4t-ethoxycarbonyl-cyclohexen-(1)eller syreadditionssalte deraf
SE7506576L (sv) Forfarande for framstellning av 3-metyl-4-fenyl-3-butensyra.
DK143559C (da) Analogifremgangsmaade til fremstilling af 5'-heptamethylenimino-pentyl-xanthen-9-carboxylat eller syreadditionssalte deraf

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7508789-0

Effective date: 19890911

Format of ref document f/p: F